The Current Ratio as of December 2024 (TTM) for POINT Biopharma Global Inc. (PNT) is 9.14

According to POINT Biopharma Global Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.14. This represents a change of 14.62% compared to the average of 7.97 of the last 4 quarters.

POINT Biopharma Global Inc. (PNT) Historical Current Ratio (quarterly & annually)

How has PNT Current Ratio performed in the past?

The mean historical Current Ratio of POINT Biopharma Global Inc. over the last ten years is 9.93. The current 9.14 Current Ratio has changed 9.10% with respect to the historical average. Over the past ten years (40 quarters), PNT's Current Ratio was at its highest in in the September 2021 quarter at 32.03. The Current Ratio was at its lowest in in the June 2020 quarter at 0.

POINT Biopharma Global Inc. (PNT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of POINT Biopharma Global Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

POINT Biopharma Global Inc. (PNT) Average Current Ratio

How has PNT Current Ratio performed in the past?

The current Current Ratio of POINT Biopharma Global Inc. (PNT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

POINT Biopharma Global Inc. (PNT) Current Ratio vs. Peers

How is PNT’s Current Ratio compared to its peers?

POINT Biopharma Global Inc.’s Current Ratio is less than ORIC Pharmaceuticals, Inc. (13.15), greater than Lyra Therapeutics, Inc. (3.64), greater than Inhibrx Biosciences, Inc. (4.70), less than ESSA Pharma Inc. (38.64), less than Crinetics Pharmaceuticals, Inc. (16.38), greater than ALX Oncology Holdings Inc. (4.82), greater than Immatics N.V. (3.98), greater than BioAtla, Inc. (3.11), greater than Aerovate Therapeutics, Inc. (8.78), less than Cerevel Therapeutics Holdings, Inc. (10.22), less than RAPT Therapeutics, Inc. (9.90), less than Cyteir Therapeutics, Inc. (21.89), less than Pardes Biosciences, Inc. (9.81), less than Third Harmonic Bio, Inc. (42.50), less than PMV Pharmaceuticals, Inc. (13.98), less than Edgewise Therapeutics, Inc. (26.35), greater than Enochian Biosciences, Inc. (0.08), less than Revolution Medicines, Inc. (14.24), less than NewAmsterdam Pharma Company N.V. (10.61), less than Centessa Pharmaceuticals plc (21.52), greater than Sutro Biopharma, Inc. (3.09), greater than Opthea Limited (2.94), less than HilleVax, Inc. (14.25),

Build a custom stock screener for POINT Biopharma Global Inc. (PNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like POINT Biopharma Global Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

POINT Biopharma Global Inc. (PNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like POINT Biopharma Global Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.